Effects of early diet resumption on the incidence of complications following polypectomy: A randomized controlled trial

Table 5 Subgroup analysis of patients with neoplastic polyp or non-neoplastic polyp in experimental group and control group, n (%)

Characteristic	Neoplastic polyp (n = 1200)			Non-neoplastic polyp (n = 302)
	Experimental group (n = 581)	Control group (n = 619)	P value	Experimental group (n = 170)	Control group (n = 132)	P value
Age (years) (mean ± SD)	57.6 ± 10.7	57.2 ± 11.3	0.387	54.9 ± 12.4	53.8 ± 12.1	0.463
Sex			0.251			0.248
Male	354 (60.9)	397 (64.1)		101 (59.4)	87 (65.9)
Female	227 (39.1)	222 (35.9)		69 (40.6)	45 (34.1)
Duration of polypectomy (minute) [median (P25, P75)]	22 (16, 31)	22 (16, 31)	0.480	20 (14, 28)	21 (16, 31)	0.101
Polyp size (cm) [median (P25, P75)]	1.0 (0.8, 1.1)	1.0 (0.8, 1.1)	0.928	0.8 (0.7, 1.0)	0.8 (0.7, 1.0)	0.191
Polypectomy modality			0.537			0.872
Cold forceps polypectomy and cold snare polypectomy	59 (10.2)	69 (11.1)		27 (15.9)	18 (13.6)
Hot snare polypectomy and endoscopic mucosal resection	510 (87.8)	532 (85.9)		140 (82.4)	112 (84.8)
Hybrid endoscopic submucosal dissection	12 (2.1)	18 (2.9)		3 (1.8)	2 (1.5)
DPPB	27 (4.6)	32 (5.2)	0.676	8 (4.7)	9 (6.8)	0.430
Major bleeding	10 (1.7)	12 (1.9)	0.779	1 (0.6)	4 (3.0)	0.232
The timing of DPPB (day) [median (P25, P75)]	2.0 (1.0, 3.0)	2.0 (1.0, 3.0)	0.367	2.0 (2.0, 2.8)	2.0 (1.0, 4.0)	0.724
The timing of major bleeding (day) [median (P25, P75)]	2.5 (1.0, 3.3)	2.0 (2.0, 3.0)	0.864	2.0	3.0 (1.3, 4.0)	0.709
Post-polypectomy perforation	0 (0.0)	2 (0.3)	0.500	0 (0.0)	0 (0.0)	-
Post-polypectomy hypoglycemia	3 (0.5)	7 (1.1)	0.394	0 (0.0)	4 (3.0)	0.075
Post-polypectomy fever	10 (1.7)	18 (2.9)	0.174	6 (3.5)	4 (3.0)	1.000
Post-polypectomy length of stay (day) [median (P25, P75)]	1.0 (1.0, 2.0)	2.0 (1.0, 2.0)	< 0.001b	1.0 (1.0, 2.0)	2.0 (1.0, 2.0)	< 0.001b

^bP < 0.01.

DPPB: Delayed post-polypectomy bleeding.